INVESTOR RELATIONS
KEY FIGURES
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions.
In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases.
Kedrion distributes its products in over 100 countries and is the world’s 5th top player in the field of plasma-derived products.

FINANCIAL REPORTS
OTHER DOCUMENTS
For more information please contact: [email protected]